Ovid Therapeutics Inc. (OVID) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Join SI Premium – FREE
Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12).
For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises TSMC price target to NT$4,000, keeps Buy rating
- Stocks expected to have increasing option volume: APLD LEVI NG TLRY UAA US
- Increasing unusual option volume: ABUS PACB DNA GMAB TWST HHH
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
